| Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway Z Li, P Razavi, Q Li, W Toy, B Liu, C Ping, W Hsieh, F Sanchez-Vega, ... Cancer Cell 34 (6), 893-905. e8, 2018 | 368 | 2018 |
| Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders S Su, Z Yang, H Gao, H Yang, S Zhu, Z An, J Wang, Q Li, ... Journal of medicinal chemistry 62 (16), 7575-7582, 2019 | 144 | 2019 |
| KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function K Gala, Q Li, A Sinha, P Razavi, M Dorso, F Sanchez-Vega, YR Chung, ... Oncogene 37 (34), 4692-4710, 2018 | 120 | 2018 |
| INK4 tumor suppressor proteins mediate resistance to CDK4/6 kinase inhibitors Q Li, B Jiang, J Guo, H Shao, IS Del Priore, Q Chang, R Kudo, Z Li, ... Cancer Discovery 12 (2), 356-371, 2022 | 83 | 2022 |
| L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function Y Xia, Q Li, W Zhong, J Dong, Z Wang, C Wang Diabetology & metabolic syndrome 3 (1), 1-10, 2011 | 71 | 2011 |
| HER2+ breast cancers evade anti-HER2 therapy via a switch in driver pathway AE Smith, E Ferraro, A Safonov, CB Morales, EJA Lahuerta, Q Li, A Kulick, ... Nature communications 12 (1), 1-10, 2021 | 54 | 2021 |
| Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma Q Li, H Wang, G Zogopoulos, Q Shao, K Dong, F Lv, K Nwilati, X Gui, ... Oncotarget 7 (47), 77838, 2016 | 52 | 2016 |
| IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin S Chowdhury, X Wang, CB Srikant, Q Li, M Fu, YJ Gong, G Ning, JL Liu Endocrinology 155 (5), 1629-1642, 2014 | 39 | 2014 |
| Reg2 Expression Is Required for Pancreatic Islet Compensation in Response to Aging and High-Fat Diet–Induced Obesity Q Li, B Li, X Miao, C Ramgattie, Z Gao, JL Liu Endocrinology 158 (6), 1634-1644, 2017 | 27 | 2017 |
| Molecular profiling of ER+ metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors. P Razavi, CH dos Anjos, DN Brown, L Qing, C Ping, J Herbert, J Colon, ... Journal of Clinical Oncology 37 (15_suppl), 1009-1009, 2019 | 19 | 2019 |
| REG3A/REG3B promotes acinar to ductal metaplasia through binding to EXTL3 and activating the RAS-RAF-MEK-ERK signaling pathway H Zhang, ALG Corredor, J Messina-Pacheco, Q Li, G Zogopoulos, ... Communications Biology 4 (1), 1-13, 2021 | 15 | 2021 |
| Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets JL Liu, N Kaddour, S Chowdhury, Q Li, Z Gao Journal of diabetes 9 (5), 462-474, 2017 | 15 | 2017 |
| The contribution of Reg family proteins to cell growth and survival in pancreatic islets Q Li, X Xiong, JL Liu Islets of Langerhans 2, 1-30, 2014 | 10 | 2014 |
| Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix SH Kim, T Basili, H Dopeso, A Da Cruz Paula, R Bi, S Issa Bhaloo, ... The Journal of Pathology, 2022 | 4 | 2022 |
| Deteriorated high-fat diet-induced diabetes caused by pancreatic β-cell-specific overexpression of Reg3β gene in mice X Xiong, Q Li, W Cui, ZH Gao, JL Liu Endocrine 54 (2), 360-370, 2016 | 4 | 2016 |
| Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation S Irani, W Tan, Q Li, W Toy, C Jones, M Gadiya, A Marra, ... The Journal of Clinical Investigation, 2023 | 3 | 2023 |
| REG3β Plays a Key Role in IL17RA Protumoral Effect Q Li, JL Liu, ZH Gao Cancer research 76 (7), 2050-2050, 2016 | 3 | 2016 |
| Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion R Kudo, A Safonov, EM da Silva, Q Li, H Shao, M Will, A Fushimi, ... bioRxiv, 2023.08. 25.554716, 2023 | 1 | 2023 |
| Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity P Razavi, Q Li, Z Li, DN Brown, C Ping, R Shen, F Sanchez-Vega, ... Cancer Research 79 (13_Supplement), 927-927, 2019 | | 2019 |
| CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer Q Li, P Razavi, Z Li, AFDC Paula, E Brogi, M Scaltriti, JS Reis-Filho, ... Cancer Research 79 (13_Supplement), 4413-4413, 2019 | | 2019 |
Sarat ChandarlapatyMember, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
